Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Allogeneic hematopoietic cell transplantation in solid tumors].

J O Bay1, B Choufi, O Tournilhac

  • 1Unité de transplantation médullaire, Centre régional de lutte contre le cancer Jean-Perrin, BP 392, 63011 Clermont-Ferrand Cedex 01. olivier.bay@cjp.u-clermont1.fr

Bulletin Du Cancer
|October 18, 2001
PubMed
Summary

Allogeneic bone marrow transplantation shows promise for treating hematologic malignancies and solid tumors. Researchers are exploring reduced toxicity regimens and the graft-versus-tumor effect to improve patient outcomes and minimize side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Bone marrow transplantation·2026
Same author

Foliar efficacy of phosphorous formulations for rainfed cotton with graded levels.

Scientific reports·2026
Same author

Tuberculosis after allogeneic hematopoietic stem cell transplantation: a decade nationwide case-control retrospective study in low-incidence country.

Bone marrow transplantation·2026
Same author

Hypoventilation training including maximal end-expiratory breath holding improves the ability to repeat high-intensity efforts in elite judo athletes.

Frontiers in physiology·2024
Same author

Can an online battery match in-person cognitive testing in providing information about age-related cortical morphology?

Brain imaging and behavior·2024
Same author

Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry.

Bone marrow transplantation·2024

Area of Science:

  • Hematology and Oncology
  • Immunology

Context:

  • Allogeneic bone marrow transplantation (BMT) is a standard treatment for hematologic malignancies.
  • Traditional BMT involves myeloablative conditioning, which has significant toxicities.
  • Graft-versus-leukemia (GvL) is a key mechanism of efficacy in BMT for leukemia.

Purpose:

  • To review the current status and future potential of allogeneic transplantation for solid tumors.
  • To discuss the challenges and developments in non-myeloablative conditioning regimens.
  • To evaluate the graft-versus-tumor (GvT) effect in solid tumor treatment.

Summary:

  • Allogeneic transplantation is being adapted for solid tumors, leveraging the graft-versus-tumor (GvT) effect.
  • Non-myeloablative conditioning regimens aim to reduce toxicity compared to traditional myeloablative approaches.

Related Experiment Videos

  • Early results in renal carcinomas are encouraging, but efficacy for other solid tumors requires further investigation.

    • Impact:

    • Potential for improved treatment strategies for solid tumors using immunotherapy.
    • Reduced treatment-related toxicity and opportunistic infections in transplant recipients.
    • Advancement of allogeneic transplantation as a viable therapeutic option beyond hematologic cancers.